Uncategorized
Useful vision restored in retinitis pigmentosa patients who received subretinal implant
More than half of patients with severe retinitis pigmentosa who received the Alpha IMS subretinal implant recovered functional vision, according to results from a second human clinical trial of the device. The trial examined nine patients for a 3- to 9-month period after subretinal implantation of the Alpha IMS (Retina Implant), a 3 mm × 3 mm, 1,500-pixel device designed to restore vision without externally visible equipment.